Pediatric Brain Tumor Foundation celebrates FDA approval of Day One Biopharmaceuticals’ OJEMDA™, new treatment for common pediatric brain tumor type
GlobeNewswire
Early research funding from the PLGA Foundation contributed to development of OJEMDA (tovorafenib), the first-of-its-kind treatment..